ニューヨークにおける食道扁平上皮癌の臨床試験
ニューヨーク内の拠点で、食道扁平上皮癌に関する14件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Hematology-Oncology Associates of Central NY, P.C. ( Site 4925), East Syracuse
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05319730A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- START New York, Lake Success
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07730021A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07217171Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, New York
- Research Site, Stony Brook
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06535607A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute, Buffalo
- START New York Long Island, Lake Success
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07602842A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Maimonides Cancer Center, Brooklyn
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/04更新 · NCT06644781A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- START New York, Lake Success
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
- 他7件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Study of XB010 in Subjects With Solid Tumors
- Montefiore Medical Center - Montefiore Medical Park, The Bronx
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/22更新 · NCT06545331A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- START New York Long Island, LLC, Lake Success
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/18更新 · NCT07503808First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07284186A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 107, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。